Updates are available Correction dated 2024-01-29

Article History

Received: 8 September 2023

Accepted: 5 December 2023

First Online: 8 January 2024

Change Date: 29 January 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s00134-024-07323-9

Declarations

:

: CLM has nothing to disclose. KB has received grants from Werfen GmbH Ltd. NC has received study grants from national agencies: DSTL, Welcome Trust, MRC, and Investigator led grants from commercial companies: CSL Behring, SOBI. She has received honoraria for lectures from the Limbic and support for attending meetings from LFB, CSL Behring and SOBI. NC participates on an Advisory Board from Octapharma. NPJ has nothing to disclose. LMM has received honoraria for lectures from Octapharma, Ferrer Hospital (Haemonetics) and Werfen. She has received support for attending meetings and/or travel from ESAIC and Croatian Society of Anesthesiology. MDN has received grants from National Institutes of Health, National Institute of General Medical Services, Haemonetics, Alexion and Instrumentation Laboratories, honoraria for lectures from Haemonetics and Takeda, payment for expert testimony from Romanucci Blandon Law and Matis Baum O’Connor, support for attending meetings and/or travel from Takeda; participates on a Data Safety Monitoring Board or Advisory Board from NHLBI CONNECTS Steering Committee; is the Chief Medical Officer, Haima Therapeutics, and has Patents planned, issued or pending (US Patent 11,408.844; US Patent 9.072,760). BS has received book royalties from Elsevier, consulting fees from Chilled Platelets Study and supporting fees for attending meetings from Biomedical Excellence for Safer Transfusion. APJV has nothing to disclose. JH has received honoraria for lectures from Asahi Kasei, Diagnostica Stago, Pfizer PFE and Sanofi Aventis France.

: This study has been authorised by ethical committee (Comité de Protection des Personnes Nord Ouest IV 2018-A03446-49).